PRECLINICAL STAGE · MITOCHONDRIAL BIOLOGY
Targeting the Cellular Engines of Neurodegeneration
- Alzheimer'sLEAD PROGRAM
- BrainDISEASE PATHOLOGY
- 3PROGRAMS ACTIVE
BIOCIENT
Mitochondrial dysfunction is increasingly implicated in the onset of Alzheimer's disease.
We are developing small-molecule therapeutics that target bioenergetic failure — an early and potentially tractable driver of neurodegeneration.
About design thinking. Business leaders have not yet fully embraced it as a means of managing the constant pace of change in today's climate. This process is an essential tool that will give entrepreneurs the edge they need to succeed. About design thinking. Business leaders have not yet fully embraced it as a means of managing the constant pace of change in today's climate. This process is an essential tool that will give entrepreneurs the edge they need to succeed.
About design thinking. Business leaders have not yet fully embraced it as a means of managing the constant pace of change in today's climate. This process is an essential tool that will give entrepreneurs the edge they need to succeed. About design thinking. Business leaders have not yet fully embraced it as a means of managing the constant pace of change in today's climate. This process is an essential tool that will give entrepreneurs the edge they need to succeed.
SCIENTIFIC PRESENCE
Conferences & presentations
We are developing small-molecule therapeutics that target bioenergetic failure — an early and potentially tractable driver of neurodegeneration.
CAREERS
Join our team
From discovery through preclinical development, our work depends on rigorous science and the people behind it. If you'd like to contribute, explore our open positions or share your CV with us.
Contact us:
© 2026 Biocient Inc. All Rights Reserved.